[EN] COMPOUNDS FOR REDUCING GLUCOCORTICOIDS, AND METHODS OF TREATMENT THEREOF<br/>[FR] COMPOSÉS PERMETTANT DE RÉDUIRE LES GLUCOCORTICOÏDES, ET PROCÉDÉS DE TRAITEMENT ASSOCIÉS
申请人:BIONICHE LIFE SCIENCES INC
公开号:WO2014071506A1
公开(公告)日:2014-05-15
A method for reducing glucocorticoids in an animal in need thereof comprising the use of compounds of the formula (I), wherein the definitions for R', R1-R11 and n are as disclosed in the description. The compounds of formula (I) are for the treatment or prevention of a glucocorticoid-related disorder for maintaining bone density, maintaining and improving the immune system, treating Cushing' s syndrome, treating obesity, improving reproduction efficiency, treating metabolic disorder, treating hypertension, treating hyperglycemia, treating insulin resistance, treating type 2 diabetes, and/or aiding in cancer and immune therapies
Compounds for Reducing Glucocorticoids, and Methods of Treatment Thereof
申请人:BIONICHE LIFE SCIENCES INC.
公开号:US20150272922A1
公开(公告)日:2015-10-01
A method for reducing glucocorticoids in an animal in need thereof comprising the use of compounds of the formula (I), wherein the definitions for R′, R
1
-R
11
and n are as disclosed in the description. The compounds of formula (I) are for the treatment or prevention of a glucocorticoid-related disorder for maintaining bone density, maintaining and improving the immune system, treating Cushing's syndrome, treating obesity, improving reproduction efficiency, treating metabolic disorder, treating hypertension, treating hyperglycemia, treating insulin resistance, treating type 2 diabetes, and/or aiding in cancer and immune therapies
[EN] METHODS FOR DELAYING OCCURRENCE OF NEW-ONSET TYPE 2 DIABETES AND FOR SLOWING PROGRESSION OF AND TREATING TYPE 2 DIABETES<br/>[FR] PROCÉDÉS POUR RETARDER L'APPARITION D'UN NOUVEAU DEBUT DE DIABÈTE DE TYPE 2 DE TYPE 2 ET POUR RALENTIR LA PROGRESSION ET TRAITER LE DIABÈTE DE TYPE 2
申请人:DALCOR PHARMA UK LTD LEATHERHEAD ZUG BRANCH
公开号:WO2020030814A1
公开(公告)日:2020-02-13
The invention provides compositions and methods useful for delaying occurrence of new- onset type 2 diabetes, slowing progression of type 2 diabetes, treating type 2 diabetes, and slowing progression of a complication of type 2 diabetes.